Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'23
Jun'23
Mar'23
Dec'22
Sep'22
Jun'22
Mar'22
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Raw Material Cost
0.02
0.16
0.16
0.15
0.15
0.01
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
4.86
4.51
4.50
4.94
4.38
4.72
4.03
Other Expenses
1.15
1.29
1.24
1.04
1.14
0.73
0.65
Total Expenditure (Excl Depreciation)
16.40
17.59
17.05
15.48
15.95
12.08
10.58
Operating Profit (PBDIT) excl Other Income
-16.4
-17.6
-17.1
-15.5
-15.9
-12.1
-10.600000000000001
Other Income
2.90
2.78
2.47
1.76
1.20
0.43
0.08
Operating Profit (PBDIT)
-13.48
-14.65
-14.43
-13.56
-14.60
-11.64
-10.50
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
-0.02
-0.16
-0.16
-0.15
-0.15
-0.01
-0.00
Depreciation
0.02
0.16
0.16
0.15
0.15
0.01
0.00
Profit Before Tax
-13.50
-14.80
-14.59
-13.72
-14.74
-11.65
-10.50
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-13.50
-14.80
-14.59
-13.72
-14.74
-11.65
-10.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-13.50
-14.80
-14.59
-13.72
-14.74
-11.65
-10.50
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-13.50
-14.80
-14.59
-13.72
-14.74
-11.65
-10.50
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
224.52
234.08
245.49
207.62
218.59
229.00
237.85
Earnings per share (EPS)
-0.31
-0.34
-0.34
-0.35
-0.38
-0.3
-0.27
Diluted Earnings per share
-0.31
-0.34
-0.34
-0.35
-0.38
-0.3
-0.27
Operating Profit Margin (Excl OI)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Gross Profit Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
PAT Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2023 is 0.00% vs 0.00% in Sep 2022
Consolidate Net Profit
YoY Growth in quarter ended Sep 2023 is 8.16% vs -98.65% in Sep 2022
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2023 is -3.80% vs -113.51% in Sep 2022
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2023 has improved from Sep 2022
Compare Quarterly Results Of Theseus Pharmaceuticals, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
0.00
0.00
0.00
Raw Material Cost
0.02
3.20
-3.18
-99.38%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
4.86
7.42
-2.56
-34.50%
Other Expenses
1.15
2.37
-1.22
-51.48%
Total Expenditure (Excl Depreciation)
16.40
34.28
-17.88
-52.16%
Operating Profit (PBDIT) excl Other Income
-16.40
-34.28
17.88
52.16%
Other Income
2.90
2.12
0.78
36.79%
Operating Profit (PBDIT)
-13.48
-28.96
15.48
53.45%
Interest
0.00
0.00
0.00
Exceptional Items
0.00
-0.38
0.38
100.00%
Gross Profit (PBDT)
-0.02
-3.20
3.18
99.38%
Depreciation
0.02
3.20
-3.18
-99.38%
Profit Before Tax
-13.50
-32.54
19.04
58.51%
Tax
0.00
0.00
0.00
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-13.50
-32.54
19.04
58.51%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-13.50
-32.54
19.04
58.51%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-13.50
-32.54
19.04
58.51%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
224.52
209.90
14.62
6.97%
Earnings per share (EPS)
-0.31
-0.38
0.07
18.42%
Diluted Earnings per share
-0.31
-0.38
0.07
18.42%
Operating Profit Margin (Excl OI)
0.00%
0.00%
0.00
0.00%
Gross Profit Margin
0.00%
0.00%
0.00
0.00%
PAT Margin
0.00%
0.00%
0.00
0.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
No Net Sales in the last few periods
Quarterly - Consolidate Net Profit
Consolidate Net Profit -1.35 Million
in Sep 2023Figures in Million
QoQ Growth in quarter ended Sep 2023 is 8.78% vs -1.37% in Jun 2023
YoY Growth in quarter ended Sep 2023 is 8.16% vs -98.65% in Sep 2022
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.64 Million
in Sep 2023Figures in Million
QoQ Growth in quarter ended Sep 2023 is 5.75% vs -2.96% in Jun 2023
YoY Growth in quarter ended Sep 2023 is -3.80% vs -113.51% in Sep 2022
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
No Operating Profit Margin (Excl OI) in the last few periods






